These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
304 related items for PubMed ID: 32937203
1. 4-Amino-1,2,4-triazole-3-thione-derived Schiff bases as metallo-β-lactamase inhibitors. Gavara L, Sevaille L, De Luca F, Mercuri P, Bebrone C, Feller G, Legru A, Cerboni G, Tanfoni S, Baud D, Cutolo G, Bestgen B, Chelini G, Verdirosa F, Sannio F, Pozzi C, Benvenuti M, Kwapien K, Fischer M, Becker K, Frère JM, Mangani S, Gresh N, Berthomieu D, Galleni M, Docquier JD, Hernandez JF. Eur J Med Chem; 2020 Dec 15; 208():112720. PubMed ID: 32937203 [Abstract] [Full Text] [Related]
9. Sulfamoyl Heteroarylcarboxylic Acids as Promising Metallo-β-Lactamase Inhibitors for Controlling Bacterial Carbapenem Resistance. Wachino JI, Jin W, Kimura K, Kurosaki H, Sato A, Arakawa Y. mBio; 2020 Mar 17; 11(2):. PubMed ID: 32184250 [Abstract] [Full Text] [Related]
10. Optimization of 1,2,4-Triazole-3-thiones toward Broad-Spectrum Metallo-β-lactamase Inhibitors Showing Potent Synergistic Activity on VIM- and NDM-1-Producing Clinical Isolates. Legru A, Verdirosa F, Vo-Hoang Y, Tassone G, Vascon F, Thomas CA, Sannio F, Corsica G, Benvenuti M, Feller G, Coulon R, Marcoccia F, Devente SR, Bouajila E, Piveteau C, Leroux F, Deprez-Poulain R, Deprez B, Licznar-Fajardo P, Crowder MW, Cendron L, Pozzi C, Mangani S, Docquier JD, Hernandez JF, Gavara L. J Med Chem; 2022 Dec 22; 65(24):16392-16419. PubMed ID: 36450011 [Abstract] [Full Text] [Related]
12. Discovery of 1-Hydroxypyridine-2(1H)-thione-6-carboxylic Acid as a First-in-Class Low-Cytotoxic Nanomolar Metallo β-Lactamase Inhibitor. Shin WS, Bergstrom A, Bonomo RA, Crowder MW, Muthyala R, Sham YY. ChemMedChem; 2017 Jun 07; 12(11):845-849. PubMed ID: 28482143 [Abstract] [Full Text] [Related]
13. The structure of the metallo-β-lactamase VIM-2 in complex with a triazolylthioacetamide inhibitor. Christopeit T, Yang KW, Yang SK, Leiros HK. Acta Crystallogr F Struct Biol Commun; 2016 Nov 01; 72(Pt 11):813-819. PubMed ID: 27834790 [Abstract] [Full Text] [Related]
14. 1,4,7-Triazacyclononane Restores the Activity of β-Lactam Antibiotics against Metallo-β-Lactamase-Producing Enterobacteriaceae: Exploration of Potential Metallo-β-Lactamase Inhibitors. Somboro AM, Amoako DG, Osei Sekyere J, Kumalo HM, Khan R, Bester LA, Essack SY. Appl Environ Microbiol; 2019 Feb 01; 85(3):. PubMed ID: 30478231 [Abstract] [Full Text] [Related]
15. Hydroxyhexylitaconic acids as potent IMP-type metallo-β-lactamase inhibitors for controlling carbapenem resistance in Enterobacterales. Wachino J-i, Jin W, Norizuki C, Kimura K, Tsuji M, Kurosaki H, Arakawa Y. Microbiol Spectr; 2024 Mar 05; 12(3):e0234423. PubMed ID: 38315122 [Abstract] [Full Text] [Related]
16. Metallo-β-lactamase inhibitors by bioisosteric replacement: Preparation, activity and binding. Skagseth S, Akhter S, Paulsen MH, Muhammad Z, Lauksund S, Samuelsen Ø, Leiros HS, Bayer A. Eur J Med Chem; 2017 Jul 28; 135():159-173. PubMed ID: 28445786 [Abstract] [Full Text] [Related]
17. Structure-guided optimization of 1H-imidazole-2-carboxylic acid derivatives affording potent VIM-Type metallo-β-lactamase inhibitors. Yan YH, Li W, Chen W, Li C, Zhu KR, Deng J, Dai QQ, Yang LL, Wang Z, Li GB. Eur J Med Chem; 2022 Jan 15; 228():113965. PubMed ID: 34763944 [Abstract] [Full Text] [Related]
18. Virtual screening identifies broad-spectrum β-lactamase inhibitors with activity on clinically relevant serine- and metallo-carbapenemases. Spyrakis F, Santucci M, Maso L, Cross S, Gianquinto E, Sannio F, Verdirosa F, De Luca F, Docquier JD, Cendron L, Tondi D, Venturelli A, Cruciani G, Costi MP. Sci Rep; 2020 Jul 29; 10(1):12763. PubMed ID: 32728062 [Abstract] [Full Text] [Related]